​

Phio Pharmaceuticals Ownership | Who Owns Phio Pharmaceuticals?

OverviewRevenueFinancialsChart

Phio Pharmaceuticals Ownership Summary

Phio Pharmaceuticals is owned by 4.22% institutional investors, and 95.78% retail investors. Bridgeway Ultra-Small Company is the top mutual fund, with 0.30% of its assets in Phio Pharmaceuticals shares.

PHIO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPhio Pharmaceuticals4.22%-95.78%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202211-15.38%575,219-20.85%414.91%3-57.14%775.00%
Sep 30, 20221330.00%726,716-6.72%516.35%7133.33%4-33.33%
Jun 30, 202210-23.08%779,03610.17%520.98%3-57.14%620.00%
Mar 31, 202213-27.78%707,147-28.55%59.75%7-30.00%566.67%
Dec 31, 202118-989,68010.10%716.58%1011.11%3-40.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Bridgeway Ultra-Small Company23.49K0.30%-
Fidelity Extended Market Index4.29K0.25%-
Vanguard Institutional Extnd Mkt Idx Tr2.71K0.16%-
Fidelity Series Total Market Index1.13K0.07%-451.00
Fidelity Nasdaq Composite Index317.000.04%-
Northern Trust Extended Eq Market Idx43.000.01%-
Spartan Extended Market Index Pool E81.000.00%-
SSgA U.S. Extended Market Index Class I225.000.00%-
NT Ext Equity Mkt Idx Fd - L43.000.00%-
State St US Extended Mkt Indx NL Cl C25.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 07, 2024Bitterman Robert J President & CEOBuy$740.00
Jun 06, 2024Bitterman Robert J President & CEOBuy$750.00
Feb 26, 2024Bitterman Robert J President & CEOBuy$2.27K
Jun 30, 2023Bitterman Robert J President & CEOBuy$2.88K
Jul 01, 2023Bitterman Robert J President & CEOBuy$2.84K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q22-
2024 Q11-
2023 Q4--
2023 Q31-

PHIO Ownership FAQ

Who Owns Phio Pharmaceuticals?

Phio Pharmaceuticals shareholders are primarily institutional investors at 4.22%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Phio Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Phio Pharmaceuticals falls below.

Does Blackrock own Phio Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Phio Pharmaceuticals.

Who is the top mutual fund holder of Phio Pharmaceuticals shares?

Bridgeway Ultra-Small Company is the top mutual fund holder of Phio Pharmaceuticals shares, with 0.30% of its total shares outstanding invested in 23.49K Phio Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools